PMID- 26755815 OWN - NLM STAT- MEDLINE DCOM- 20170109 LR - 20170110 IS - 1708-8267 (Electronic) IS - 1081-5589 (Linking) VI - 64 IP - 1 DP - 2016 Jan TI - Plasma thyroid hormone concentration is associated with hepatic triglyceride content in patients with type 2 diabetes. PG - 63-8 LID - 10.1136/jim-2015-000019 [doi] AB - The underlying mechanisms responsible for the development and progression of non-alcoholic fatty liver disease (NAFLD) in patients with type 2 diabetes mellitus (T2DM) are unclear. Since the thyroid hormone regulates mitochondrial function in the liver, we designed this study in order to establish the association between plasma free T4 levels and hepatic triglyceride accumulation and histological severity of liver disease in patients with T2DM and NAFLD. This is a cross-sectional study including a total of 232 patients with T2DM. All patients underwent a liver MR spectroscopy ((1)H-MRS) to quantify hepatic triglyceride content, and an oral glucose tolerance test to estimate insulin resistance. A liver biopsy was performed in patients with a diagnosis of NAFLD. Patients were divided into 5 groups according to plasma free T4 quintiles. We observed that decreasing free T4 levels were associated with an increasing prevalence of NAFLD (from 55% if free T4>/=1.18 ng/dL to 80% if free T4<0.80 ng/dL, p=0.016), and higher hepatic triglyceride accumulation by (1)H-MRS (p<0.001). However, lower plasma free T4 levels were not significantly associated with more insulin resistance or more severe liver histology (ie, inflammation, ballooning, or fibrosis). Decreasing levels of plasma free T4 are associated with a higher prevalence of NAFLD and increasing levels of hepatic triglyceride content in patients with T2DM. These results suggest that thyroid hormone may play a role in the regulation of hepatic steatosis and support the notion that hypothyroidism may be associated with NAFLD. No NCT number required. CI - Copyright (c) 2016 American Federation for Medical Research. FAU - Bril, Fernando AU - Bril F AD - Division of Endocrinology, Diabetes and Metabolism, University of Florida, Gainesville, Florida, USA Malcom Randall VAMC, Gainesville, Florida, USA. FAU - Kadiyala, Sushma AU - Kadiyala S AD - Division of Endocrinology, Diabetes and Metabolism, University of Florida, Gainesville, Florida, USA Malcom Randall VAMC, Gainesville, Florida, USA. FAU - Portillo Sanchez, Paola AU - Portillo Sanchez P AD - Division of Endocrinology, Diabetes and Metabolism, University of Florida, Gainesville, Florida, USA Malcom Randall VAMC, Gainesville, Florida, USA. FAU - Sunny, Nishanth E AU - Sunny NE AD - Division of Endocrinology, Diabetes and Metabolism, University of Florida, Gainesville, Florida, USA. FAU - Biernacki, Diane AU - Biernacki D AD - Division of Endocrinology, Diabetes and Metabolism, University of Florida, Gainesville, Florida, USA Malcom Randall VAMC, Gainesville, Florida, USA. FAU - Maximos, Maryann AU - Maximos M AD - Malcom Randall VAMC, Gainesville, Florida, USA Pediatric Gastroenterology, Hepatology, and Nutrition, University of Florida, Gainesville, Florida, USA. FAU - Kalavalapalli, Srilaxmi AU - Kalavalapalli S AD - Division of Endocrinology, Diabetes and Metabolism, University of Florida, Gainesville, Florida, USA. FAU - Lomonaco, Romina AU - Lomonaco R AD - Division of Endocrinology, Diabetes and Metabolism, University of Florida, Gainesville, Florida, USA Malcom Randall VAMC, Gainesville, Florida, USA. FAU - Suman, Amitabh AU - Suman A AD - Malcom Randall VAMC, Gainesville, Florida, USA Division of Gastroenterology, Hepatology, and Nutrition, University of Florida, Gainesville, Florida, USA. FAU - Cusi, Kenneth AU - Cusi K AD - Division of Endocrinology, Diabetes and Metabolism, University of Florida, Gainesville, Florida, USA Malcom Randall VAMC, Gainesville, Florida, USA Division of Diabetes, University of Texas Health Science Center at San Antonio, Texas, USA Audie L. Murphy VAMC, San Antonio, Texas, USA. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20151216 PL - England TA - J Investig Med JT - Journal of investigative medicine : the official publication of the American Federation for Clinical Research JID - 9501229 RN - 0 (Thyroid Hormones) RN - 0 (Triglycerides) SB - IM MH - Demography MH - Diabetes Mellitus, Type 2/*blood/complications MH - Female MH - Humans MH - Insulin Resistance MH - Liver/*metabolism/pathology MH - Male MH - Middle Aged MH - Mitochondria/metabolism MH - Non-alcoholic Fatty Liver Disease/blood/complications/epidemiology MH - Prevalence MH - Severity of Illness Index MH - Thyroid Hormones/*blood MH - Triglycerides/*metabolism OTO - NOTNLM OT - Diabetes Mellitus OT - Fatty Liver OT - Insulin OT - Obesity OT - Thyroid Diseases EDAT- 2016/01/13 06:00 MHDA- 2017/01/10 06:00 CRDT- 2016/01/13 06:00 PHST- 2015/11/18 00:00 [accepted] PHST- 2016/01/13 06:00 [entrez] PHST- 2016/01/13 06:00 [pubmed] PHST- 2017/01/10 06:00 [medline] AID - jim-2015-000019 [pii] AID - 10.1136/jim-2015-000019 [doi] PST - ppublish SO - J Investig Med. 2016 Jan;64(1):63-8. doi: 10.1136/jim-2015-000019. Epub 2015 Dec 16.